Breaking News, Collaborations & Alliances

Goodwin Biotechnology, IBC Generium Form Partnership

CDMO will help with the process, scale-up, and manufacture of IBC's IgG-based bispecific antibody for Phase I trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

International Biotechnology Center (IBC) Generium, a private scientific research company in Russia that develops medical products and cell-based technologies, has selected Goodwin Biotechnology, a biological contract development and manufacturing organization (CDMO) that specializes in bioprocess development and cGMP manufacturing of biopharmaceuticals utilizing mammalian cell culture expression systems and bioconjugation technologies, for the assay and process technology transfer, process scale...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters